SCHEMBL8212283

SCHEMBL8212283

Cn1nc(-c2ccccc2)c(-c2ccsc2)n1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 2/20 0.53
▸ CYP2B6 P20813 2/20 0.53
▸ CYP2E1 P05181 1/20 0.53
▸ ADORA1 P30542 2/20 0.48
▸ ADORA2A P29274 4/20 0.48
▸ NPY5R Q15761 1/20 0.43
▸ PTGER1 P34995 2/20 0.42
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ FYN P06241 1/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ GLO1 Q04760 1/20 0.39
▸ TP53 P04637 2/20 0.38
▸ GAA P10253 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ NR1H4 Q96RI1 1/20 0.38
▸ TDO2 P48775 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8214324 0.83 FYN (0.42) CYP2A6CYP2B6CYP2E1PTGER1FYN
SCHEMBL13510674 0.83 CYP2A6 (0.50) CYP2A6CYP2B6CYP2E1ADORA1ADORA2A
SCHEMBL8205966 0.82 KMT2A (0.48) ADORA1SMN1; SMN2GAAMAPT
SCHEMBL13509082 0.81 CYP2A6 (0.48) CYP2A6CYP2B6CYP2E1ADORA1ADORA2A
SCHEMBL8221922 0.80 GABRA1 (0.46) CYP2A6ADORA1GAA
SCHEMBL13996078 0.74 CYP2A6 (0.57) CYP2A6CYP2B6CYP2E1ADORA1ADORA2A
SCHEMBL8208163 0.74 ALDH1A1 (0.46) CYP2A6CYP2B6CYP2E1ADORA1ADORA2A
SCHEMBL8214143 0.72 ALDH1A1 (0.54) ADORA1ADORA2ACYP3A4CYP2C9CYP2C19
SCHEMBL15656804 0.72 ADORA1 (0.40) CYP2A6CYP2B6CYP2E1ADORA1ADORA2A
SCHEMBL8214626 0.71 PDPK1 (0.58) CYP2A6ADORA1ADORA2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008021960-A2 TRIAZOLYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2008-02-21 — — WO disclosed
Send feedback